Clinical Trial: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07344051) titled 'A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis' on Jan. 07.

Brief Summary: This trial was designed to evaluate the efficacy and safety of QLS12010 Capsules in adults with moderate-to-severe atopic dermatitis.

Study Start Date: April 05, 2026

Study Type: INTERVENTIONAL

Condition: Moderate-to-severe Atopic Dermatitis

Intervention: DRUG: QLS12010

QLS12010 oral capsule

DRUG: Placebo

Matching placebo oral capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Qilu Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....